BofA/Merrill Lynch Downgrades Teva Pharma (TEVA) to Neutral

November 7, 2016 7:11 AM EST
Get Alerts TEVA Hot Sheet
Price: $36.53 -0.11%

Rating Summary:
    21 Buy, 18 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade TEVA Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

BofA/Merrill Lynch downgraded Teva Pharma (NYSE: TEVA) from Buy to Neutral with a price target of $48.00.

For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.

Shares of Teva Pharma closed at $40.24 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment